Scientific Advisory Board
Our world-renowned board members
The Axplora Scientific Advisory Board (SAB) brings together leading international experts with complementary areas of expertise, spanning from catalysis to electrochemistry, steroids, biochemistry, and ADCs.
Mission, role & responsibilities
The advisory body plays a key role in following market trends and shaping our R&D activities and focuses on supporting the deployment of innovative technologies and modalities at Axplora. With the Board’s insight and guidance, Axplora is well-positioned to meet the challenges of API development and manufacturing for the benefit of our clients and their patients.
The SAB members help grow Axplora’s visibility as an important player in specific technologies.
Members are committed to:
- Attending regular SAB meetings every year to:
- Assess Axplora’s innovation projects and directions,
- Propose potential innovation projects, directions, and partners for Axplora.
- Participating in seminars and customer visits with Axplora’s representatives in Europe or overseas, presenting scientific lectures based on research conducted by our team to position Axplora as an innovative and scientific leader.
- Assisting Axplora in scientifically related tasks, such as literature surveys, or helping R&D personnel to solve scientific or technical issues, etc.
-
Dr. David Cantillo is a group leader and senior lecturer at the University of Queensland. He is an eminent researcher with particular expertise in flow chemistry, electrochemistry and photochemistry.
-
Prof. Alois Fürstner is currently Director at the Max-Planck-Institute für Kohlenforschung, Mülheim/Ruhr, Germany, an elite institution in the area of catalysis research for more than a century.
He is renowned for his expertise in the field of homogeneous catalysis, organometallic chemistry, and target-oriented synthesis. In recognition of his work, he received numerous awards.
Professor Fürstner has been Editor-in-Chief of “Science of Synthesis” since 2017. -
Prof. Kerry Chester is Professor of Molecular Medicine at UCL, a top global university, and she is on the Board of Directors of The Antibody Society. Kerry’s group created and manufactured the first single chain Fv antibody (scFv) to enter clinical trials. She has over 30 years’ experience in development of antibody-based therapeutics.
-
Prof. John Woodley is Professor of Chemical Engineering in the Department of Chemical and Biochemical Engineering at Technical University of Denmark.
As an expert in biochemical engineering and biocatalysis, he has collaborated with many universities (Dortmund, GE; Graz, AT; Manchester, UK; or North Carolina State University, USA) and industrial players such as Sigma-Aldrich, Novozymes, BASF and Lonza. He has received several awards and honors throughout his successful career. -
Dr. Michael Reschke is Director and consultant at Reschke Technology Consulting. He has more than 30 years’ experience in steroids and bile acids and has expertise in large-scale fermentation of steroid intermediates.